{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,15]],"date-time":"2026-11-15T00:35:46Z","timestamp":1794702946780,"version":"4.9.1"},"reference-count":54,"publisher":"MDPI AG","issue":"5","license":[{"start":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T00:00:00Z","timestamp":1772755200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>Background: The clinical use of machine learning (ML) in survival analysis is often limited by the \u201cblack box\u201d nature of complex algorithms, which makes their results difficult to interpret in practice. In this study, we propose a unified and clinically grounded framework that integrates ML-based feature selection with traditional survival analysis. This approach aims to bridge the gap between strong predictive performance and clear, clinically meaningful interpretation. Methods: High-impact prognostic clinical features were identified using ML models GBM-Cox, RSF, and LASSO-Cox with 5-fold stratified cross-validation and subsequently validated using Cox Proportional Hazards and Kaplan\u2013Meier analysis. The framework was evaluated across two distinct disease domains, Heart Failure and the METABRIC breast cancer cohort, to assess robustness and generalizability. Results: In the Heart Failure dataset, age group, serum creatinine, and blood pressure stratified patients into distinct risk groups. The high-risk group had significantly higher mortality (HR: 2.61; 95% CI: 1.42\u20134.78; p = 0.0013). In the METABRIC cohort, age at diagnosis, HER2 status, and Nottingham Prognostic Index (NPI) showed strong survival separation (p &lt; 0.001). The high-risk group had an HR of 2.73 (95% CI: 2.34\u20133.19) and the faced a significantly shorter median survival (104.7 vs. 252.3 months), representing a 12.3-year reduction in life expectancy compared to low-risk group. This prognostic separation emphasizes the predictive power of selected baseline variables. Performance remained stable across cohorts, with C-index values (0.665\u20130.794) consistent with standard clinical benchmarks. Conclusions: Integrating cross-validated machine learning feature selection with Cox-based survival analysis enables stable and clinically interpretable risk stratification across diseases. By translating ML selected predictors into hazard ratios and absolute survival differences, this framework provides a reproducible and clinically grounded approach for survival risk assessment.<\/jats:p>","DOI":"10.3390\/diagnostics16050790","type":"journal-article","created":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T11:05:44Z","timestamp":1772795144000},"page":"790","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["A Unified Framework for Survival Prediction: Combining Machine Learning Feature Selection with Traditional Survival Analysis in Heart Failure and METABRIC Breast Cancer"],"prefix":"10.3390","volume":"16","author":[{"given":"Fangya","family":"Tan","sequence":"first","affiliation":[{"name":"Department of Analytics, Harrisburg University of Science and Technology, Harrisburg, PA 17101, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5021-3739","authenticated-orcid":false,"given":"Jian-Guo","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Oncology, The Second Affiliated Hospital of Zunyi Medical University, Zunyi 563000, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuqiao","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Analytics, Harrisburg University of Science and Technology, Harrisburg, PA 17101, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bowen","family":"Long","sequence":"additional","affiliation":[{"name":"Department of Analytics, Harrisburg University of Science and Technology, Harrisburg, PA 17101, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srikar","family":"Bellur","sequence":"additional","affiliation":[{"name":"Department of Analytics, Harrisburg University of Science and Technology, Harrisburg, PA 17101, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0142-1507","authenticated-orcid":false,"given":"Yang","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Physics, The Graduate Center, City University of New York, New York, NY 10016, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Newman","sequence":"additional","affiliation":[{"name":"Department of Analytics, Harrisburg University of Science and Technology, Harrisburg, PA 17101, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,3,6]]},"reference":[{"key":"ref_1","unstructured":"Fleming, T.R., and Harrington, D.P. (1991). Counting Processes and Survival Analysis, John Wiley & Sons."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Kleinbaum, D.G., and Klein, M. (1996). Survival Analysis: A Self-Learning Text, Springer.","DOI":"10.2307\/2532873"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1200\/JCO.2009.22.7991","article-title":"Survival analysis of cancer risk reduction strategies for BRCA1\/2 mutation carriers","volume":"28","author":"Kurian","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1093\/annonc\/mdx479","article-title":"Overall survival analysis of EXAM, a phase III trial of cabozantinib in patients with radiographically progressive medullary thyroid carcinoma","volume":"28","author":"Schlumberger","year":"2017","journal-title":"Ann. Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/sim.4780010202","article-title":"Long term survival analysis: The curability of breast cancer","volume":"1","author":"Pocock","year":"1982","journal-title":"Stat. Med."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Chicco, D., and Jurman, G. (2020). Machine learning can predict survival of patients with heart failure from serum creatinine and ejection fraction alone. BMC Med. Inform. Decis. Mak., 20.","DOI":"10.1186\/s12911-020-1023-5"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.jchf.2016.08.001","article-title":"Hypertension, obesity, diabetes, and heart failure\u2013free survival: The cardiovascular disease lifetime risk pooling project","volume":"4","author":"Ahmad","year":"2016","journal-title":"JACC Heart Fail."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"4415","DOI":"10.1093\/eurheartj\/ehaa793","article-title":"Association of \u03b2-blocker use with survival and pulmonary function in patients with chronic obstructive pulmonary and cardiovascular disease: A systematic review and meta-analysis","volume":"41","author":"Yang","year":"2020","journal-title":"Eur. Heart J."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jhep.2005.10.013","article-title":"Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies","volume":"44","author":"Pagliaro","year":"2006","journal-title":"J. Hepatol."},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Guo, A., Mazumder, N.R., Ladner, D.P., and Foraker, R.E. (2021). Predicting mortality among patients with liver cirrhosis in electronic health records with machine learning. PLoS ONE, 16.","DOI":"10.1371\/journal.pone.0256428"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"e2023780","DOI":"10.1001\/jamanetworkopen.2020.23780","article-title":"Development, validation, and evaluation of a simple machine learning model to predict cirrhosis mortality","volume":"3","author":"Kanwal","year":"2020","journal-title":"JAMA Netw. Open"},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Chen, H.C., Kodell, R.L., Cheng, K.F., and Chen, J.J. (2012). Assessment of performance of survival prediction models for cancer prognosis. BMC Med. Res. Methodol., 12.","DOI":"10.1186\/1471-2288-12-102"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"2787","DOI":"10.1128\/AAC.48.8.2787-2792.2004","article-title":"Hazard ratio in clinical trials","volume":"48","author":"Spruance","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1080\/01621459.1989.10478874","article-title":"The robust inference for the Cox proportional hazards model","volume":"84","author":"Lin","year":"1989","journal-title":"J. Am. Stat. Assoc."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1214\/08-AOAS169","article-title":"Random survival forests","volume":"2","author":"Ishwaran","year":"2008","journal-title":"Ann. Appl. Stat."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1214\/aos\/1013203451","article-title":"Greedy function approximation: A gradient boosting machine","volume":"29","author":"Friedman","year":"2001","journal-title":"Ann. Stat."},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Chen, T., and Guestrin, C. (2016). XGBoost: A scalable tree boosting system. Proceedings of the 22nd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining, Association for Computing Machinery.","DOI":"10.1145\/2939672.2939785"},{"key":"ref_18","unstructured":"Prokhorenkova, L., Gusev, G., Vorobev, A., Dorogush, A.V., and Gulin, A. (2018). CatBoost: Unbiased boosting with categorical features. Advances in Neural Information Processing Systems, Curran Associates, Inc."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s10741-024-10474-y","article-title":"Machine learning in predicting heart failure survival: A review of current models and future prospects","volume":"30","author":"Kokori","year":"2025","journal-title":"Heart Fail. Rev."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Zhou, J.G., Wong, A.H.H., Wang, H., Tan, F., Chen, X., Jin, S.H., He, S.-S., Shen, G., Wang, Y.-J., and Frey, B. (2022). Elucidation of the application of blood test biomarkers to predict immune-related adverse events in atezolizumab-treated NSCLC patients using machine learning methods. Front. Immunol., 13.","DOI":"10.3389\/fimmu.2022.862752"},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Spreafico, M., Hazewinkel, A.D., van de Sande, M.A., Gelderblom, H., and Fiocco, M. (2024). Machine Learning versus Cox Models for Predicting Overall Survival in Patients with Osteosarcoma: A Retrospective Analysis of the EURAMOS-1 Clinical Trial Data. Cancers, 16.","DOI":"10.3390\/cancers16162880"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.otohns.2010.05.007","article-title":"A practical guide to understanding Kaplan-Meier curves","volume":"143","author":"Rich","year":"2010","journal-title":"Otolaryngol. Head Neck Surg."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/cncr.11859","article-title":"Is breast cancer survival improving? Trends in survival for patients with recurrent breast cancer diagnosed from 1974 through 2000","volume":"100","author":"Giordano","year":"2004","journal-title":"Cancer"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0169-5002(95)00497-1","article-title":"Survival predictors in advanced non-small cell lung cancer","volume":"13","author":"Hespanhol","year":"1995","journal-title":"Lung Cancer"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1002\/bjs.10895","article-title":"LASSO regression","volume":"105","author":"Ranstam","year":"2018","journal-title":"Br. J. Surg."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1093\/bioinformatics\/bty750","article-title":"Precision Lasso: Accounting for correlations and linear dependencies in high-dimensional genomic data","volume":"35","author":"Wang","year":"2019","journal-title":"Bioinformatics"},{"key":"ref_27","first-page":"310","article-title":"Machine-learning versus traditional approaches for atherosclerotic cardiovascular risk prognostication in primary prevention cohorts: A systematic review and meta-analysis","volume":"9","author":"Liu","year":"2023","journal-title":"Eur. Heart J. Qual. Care Clin. Outcomes"},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Panahiazar, M., Taslimitehrani, V., Pereira, N., and Pathak, J. (2015). Using EHRs and machine learning for heart failure survival analysis. MEDINFO 2015: eHealth-Enabled Health, IOS Press.","DOI":"10.3233\/978-1-61499-564-7-40"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"e2147","DOI":"10.7717\/peerj-cs.2147","article-title":"Survival analysis in breast cancer: Evaluating ensemble learning techniques for prediction","volume":"10","year":"2024","journal-title":"PeerJ Comput. Sci."},{"key":"ref_30","first-page":"e70262","article-title":"Comparison of Random Survival Forest Based-Overall Survival with Deep Learning and Cox Proportional Hazard Models in HER-2-Positive HR-Negative Breast Cancer","volume":"8","author":"Cai","year":"2025","journal-title":"Cancer Rep."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"30909","DOI":"10.1007\/s11042-023-14989-8","article-title":"Survival analysis of breast cancer patients using machine learning models","volume":"82","author":"Evangeline","year":"2023","journal-title":"Multimed. Tools Appl."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1176935118810215","DOI":"10.1177\/1176935118810215","article-title":"Machine learning with k-means dimensional reduction for predicting survival outcomes in patients with breast cancer","volume":"17","author":"Zhao","year":"2018","journal-title":"Cancer Inform."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"6968","DOI":"10.1038\/s41598-021-86327-7","article-title":"Explainable machine learning can outperform Cox regression predictions and provide insights in breast cancer survival","volume":"11","author":"Hendriks","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Doan, L.M.T., Angione, C., and Occhipinti, A. (2022). Machine learning methods for survival analysis with clinical and transcriptomics data of breast cancer. Computational Biology and Machine Learning for Metabolic Engineering and Synthetic Biology, Springer.","DOI":"10.1007\/978-1-0716-2617-7_16"},{"key":"ref_35","unstructured":"World Health Organization (2026, January 01). World Heart Day, Available online: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/cardiovascular-diseases-(cvds)."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Ahmad, T., Munir, A., Bhatti, S.H., Aftab, M., and Ali Raza, M. (2017). DATA_MINIMAL [Dataset]. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0181001"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/01.JAA.0000580524.95733.3d","article-title":"Overview of breast cancer","volume":"32","author":"Watkins","year":"2019","journal-title":"JAAPA"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nature10983","article-title":"The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups","volume":"486","author":"Curtis","year":"2012","journal-title":"Nature"},{"key":"ref_39","unstructured":"Vieira, D., Gimenez, G., Marmorela, G., and Estima, V. (2026, January 01). XGBoost survival embeddings: Improving statistical properties of XGBoost survival analysis implementation. Loft Python. Available online: https:\/\/github.com\/loft-br\/xgboost-survival-embeddings."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/(SICI)1097-0258(19970228)16:4<385::AID-SIM380>3.0.CO;2-3","article-title":"The lasso method for variable selection in the Cox model","volume":"16","author":"Tibshirani","year":"1997","journal-title":"Stat. Med."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Lee, C., Zame, W., Yoon, J., and Van Der Schaar, M. (2018). Deephit: A deep learning approach to survival analysis with competing risks. Proceedings of the AAAI Conference on Artificial Intelligence, AAAI Press.","DOI":"10.1609\/aaai.v32i1.11842"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Katzman, J.L., Shaham, U., Cloninger, A., Bates, J., Jiang, T., and Kluger, Y. (2018). DeepSurv: Personalized treatment recommender system using a Cox proportional hazards deep neural network. BMC Med. Res. Methodol., 18.","DOI":"10.1186\/s12874-018-0482-1"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1002\/sim.1802","article-title":"Overall C as a measure of discrimination in survival analysis: Model specific population value and confidence interval estimation","volume":"23","author":"Pencina","year":"2004","journal-title":"Stat. Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/0895-4356(91)90146-Z","article-title":"Assessing predictive accuracy: How to compare Brier scores","volume":"44","author":"Redelmeier","year":"1991","journal-title":"J. Clin. Epidemiol."},{"key":"ref_45","unstructured":"U.S. Food and Drug Administration (FDA) (2022). Inclusion of Older Adults in Cancer Clinical Trials: Guidance for Industry."},{"key":"ref_46","unstructured":"Mayo Clinic (2024, May 24). Ejection Fraction: What Does It Mean?. Available online: https:\/\/www.mayoclinic.org\/tests-procedures\/ekg\/expert-answers\/ejection-fraction\/faq-20058286."},{"key":"ref_47","unstructured":"Lab Tests Online (2026, January 01). Creatinine. Available online: https:\/\/www.testing.com\/tests\/creatinine\/."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/BF01840834","article-title":"The Nottingham Prognostic Index in primary breast cancer","volume":"22","author":"Galea","year":"1992","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Early Breast Cancer Trialists\u2019 Collaborative Group (EBCTCG) (2005). Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: An overview of the randomised trials. Lancet, 365, 1687\u20131717.","DOI":"10.1016\/S0140-6736(05)66544-0"},{"key":"ref_50","unstructured":"Edge, S.B., Byrd, D.R., Compton, C.C., Fritz, A.G., Greene, F.L., and Trotti, A. (2010). AJCC Cancer Staging Manual, Springer. [7th ed.]."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1136\/bmj.328.7447.1073","article-title":"The logrank test","volume":"328","author":"Bland","year":"2004","journal-title":"BMJ"},{"key":"ref_52","doi-asserted-by":"crossref","unstructured":"Nak, D., and Kivrak, M. (2024). Mastectomy, HER2 receptor positivity, NPI, late stage and luminal B-type tumor as poor prognostic factors in geriatric patients with breast cancer. Diagnostics, 15.","DOI":"10.3390\/diagnostics15010013"},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Kamarudin, A.N., Cox, T., and Kolamunnage-Dona, R. (2017). Time-dependent ROC curve analysis in medical research: Current methods and applications. BMC Med. Res. Methodol., 17.","DOI":"10.1186\/s12874-017-0332-6"},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Baidoo, T.G., and Rodrigo, H. (2025). Data-driven survival modeling for breast cancer prognostics: A comparative study with machine learning and traditional survival modeling methods. PLoS ONE, 20.","DOI":"10.1371\/journal.pone.0318167"}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/16\/5\/790\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T11:27:12Z","timestamp":1772796432000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/16\/5\/790"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,6]]},"references-count":54,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["diagnostics16050790"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics16050790","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,6]]}}}